Australians living with type 1 diabetes will soon have access to Abbott Diabetes Care’s FreeStyle Libre 3 Plus continuous ...
The FDA authorized Abbott’s Libre Duo 10 Day on August 25, the first U.S. wearable to continuously monitor both ketones and glucose.
Tandem Diabetes Care, Inc. TNDM shares rallied 7.7% in the last trading session to close at $17.53. This move can be ...
Libre Duo 10 Day is a first-of-its-kind, two-in-one biowearable that monitors glucose and helps detect rising ketone levels that can lead to diabetic ketoacidosis (DKA), a serious health condition for ...
A single skin sensor can now warn people with diabetes before a life-threatening emergency builds.
If you experience unbearable sleepiness, lethargy, or a loss of concentration after eating, you might have "postprandial ...
The Technique Revealed by a Doctor to Escape Being a 'Slave to Appetite'—How I Lost 20kg After 100 Failures Using a Blood Sugar Control Method That Doesn't Rely on Willpower'I want to eat. But I want ...
Ketone monitoring is an essential part of type 1 diabetes management, and the availability of a dual glucose and ketone sensor could provide patients with a tool to measure levels more easily, ...
Adults with type 1 diabetes who continued or transitioned to the Omnipod 5 Automated Insulin Delivery (AID) System maintained ...
The U.S. Food and Drug Administration (FDA) on Tuesday authorized the first wearable sensor that continuously tracks ketones — chemicals the body makes when it burns fat instead of sugar for fuel. It ...
ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results